Belgium · Biotechnology startup
Belgium · UgenTec
UgenTec delivers an independent diagnostic platform to help molecular labs with their DNA (PCR) analyses.
Funding reportedLast round: Series A
What company datasets say UgenTec raised
Funding, as reported
Reported in all11.2Min the source's currency
Rounds5
Last roundSeries A
Last round dateMar 2018
Investors listed8
On a portfolio page
Investors who name them
Each firm lists UgenTec on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Biotechnology in Belgium
Startups like it
Is this your company?
Add your raise, your deck and your story, and put UgenTec in front of investors. Or tell us what we have wrong.